Stirimazole, an imidazole derivative, has demonstrated the ability to inhibit Trichomonas vaginalis in vitro at an effective concentration of 0.225 μg/ml. In animal studies, an oral dose of 20 mg/kg successfully eradicated infectious lesions in mice.